JUBILANT PHARMA
Board
4 directors, 1 auditor, last change in April 2026Perfetti Guiliano
Director
since 27-08-2021
term until 01-09-2027
listed in the 2025 annual accounts, filed on 06-10-2025
Dr. Jaidev Sanjeev Rajapi
Director
since 15-03-2023
term until 01-09-2028
listed in the 2025 annual accounts, filed on 06-10-2025
Director
since 15-03-2023
term until 01-09-2028
listed in the 2025 annual accounts, filed on 06-10-2025
Van Ohlen Michael
Director
since 31-10-2023
term until 31-03-2028
listed in the 2025 annual accounts, filed on 06-10-2025
VRC BEDRIJFSREVISOREN
Statutory auditor, permanent representative Bart Roobrouck
appointed by deed of 18-01-2023
listed in the 2025 annual accounts, filed on 06-10-2025
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Two directors jointlydeed of 19-09-2024
Mandates through the years
11 names, the dashed line is todayPerfetti Guiliano
Director
Director
Dr. Jaidev Sanjeev Rajapi
Director
Director
Rajesh Bhatia
Director
Director
Van Ohlen Michael
Director
Director
VRC BEDRIJFSREVISOREN
Statutory auditor
Statutory auditor
Perfetti Giuliano
Director
Director
Michael Von Ohlen
Director
Director
Mitchell F Guss
Director
Director
Jaidev Sanjeev Rajapl
Director
Director
Pramod Yadav
Director
Director
Taneja Puneet
Director
Director
BoardStatutory auditorEarlierRest of the termmandate already running before its first mentionend not dated
Mandates as a list
- Perfetti Guiliano
- Director, from 27-08-2021 to date
- Dr. Jaidev Sanjeev Rajapi
- Director, from 15-03-2023 to date
- Rajesh Bhatia
- Director, from 15-03-2023 to date
- Van Ohlen Michael
- Director, from 30-10-2023 to date
- VRC BEDRIJFSREVISOREN
- Statutory auditor, since before 31-03-2022
- Perfetti Giuliano
- Director, appointed by deed of 27-09-2021, until 30-04-2026
- Michael Von Ohlen
- Director, appointed by deed of 01-02-2024, no longer listed in the 2025 annual accounts
- Mitchell F Guss
- Director, from 30-12-2020 to 30-10-2023
- Jaidev Sanjeev Rajapl
- Director, appointed by deed of 20-04-2023, no longer listed in the 2025 annual accounts
- Pramod Yadav
- Director, from 31-03-2018 to 15-03-2023
- Taneja Puneet
- Director, from 30-12-2020 to 03-08-2022
Control
consolidated
This company
JUBILANT PHARMA
Equity €17.6m
Loss €12,772 in 2025
Capital
- Capital
- €16,180,000
- Shares
- 17,900,000
- Contribution per share
- €0.90
- Equity per share
- €0.99 in 2025
- Source
- 2025 annual accounts
Articles of association
deed of 19-09-2024 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 3 directors
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Friday of September at 12:00
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Alle machten artikel 2:87 Wetboek van vennootschappen en verenigingen zonder bijzondere machtiging, algemene vergadering kan te allen tijde…”